BioMark Diagnostics Inc.
BUX
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -27.74% | -11.06% | 2,702.92% | 140.63% | -75.22% |
| Total Receivables | 1.61% | 11.45% | 127.24% | -1.40% | 119.82% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -25.53% | -9.69% | 1,559.21% | 46.56% | -39.95% |
|
|
|||||
| Total Current Assets | -25.53% | -9.69% | 1,559.21% | 46.56% | -39.95% |
| Net Property, Plant & Equipment | -71.92% | -17.47% | -33.14% | -13.56% | -6.08% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 44.80% | 3.73% | 1.69% | -6.32% | 1.20% |
| Total Assets | -30.82% | -10.65% | 257.89% | -6.23% | -11.62% |
|
|
|||||
| Total Accounts Payable | -30.47% | 14.62% | -43.71% | 7.41% | 182.90% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -5.27% | 6.07% | -29.66% | 3.98% | 11.21% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -49.39% | -7.30% | 218.07% | -52.20% | -42.90% |
| Total Finance Division Other Current Liabilities | -1.64% | 5.17% | 0.00% | -6.45% | 1.64% |
| Total Other Current Liabilities | -1.64% | 5.17% | 0.00% | -6.45% | 1.64% |
| Total Current Liabilities | -20.52% | 4.73% | -18.84% | -2.09% | 17.62% |
|
|
|||||
| Total Current Liabilities | -20.52% | 4.73% | -18.84% | -2.09% | 17.62% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -5.27% | 6.07% | -29.66% | 3.98% | 11.21% |
| Capital Leases | -80.84% | -33.72% | -64.58% | -6.13% | 15.02% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -25.13% | 0.31% | -29.36% | -3.05% | 16.99% |
|
|
|||||
| Common Stock & APIC | -2.01% | 5.42% | 32.59% | -6.00% | 2.17% |
| Retained Earnings | -0.83% | -8.17% | -2.85% | 4.02% | -5.14% |
| Treasury Stock & Other | -- | -- | -- | 24.84% | 8.45% |
| Total Common Equity | -36.49% | -19.42% | 258.74% | 0.35% | -61.34% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -36.49% | -19.42% | 258.74% | 0.35% | -61.34% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -36.49% | -19.42% | 258.74% | 0.35% | -61.34% |
|
|
|||||